A. Nenisˇkis, S. Stoncˇius
= 247.6 Hz, C) ppm. IR (KBr): ν = 2938, 1711, 1604, 1587, 1226,
FULL PAPER
(CH3), 55.4 (CH3), 56.1 (CH3), 91.3 (CH), 113.0 (C), 113.6 (CH),
˜
124.9 (CH), 128.7 (C), 130.0 (CH), 132.5 (C), 147.4 (C), 150.8 (C), 1205, 1158, 1127 cm–1. HRMS (ESI): calcd. for C45H41F2N2O8 [M
158.9 (C), 159.0 (C) 159.8 (C), 161.0 (C) ppm. IR (KBr): ν = 2930, + H]+ 775.2825; found 775.2835.
˜
2850, 2836, 1712, 1608, 1583, 1512, 1454, 1247, 1224, 1205, 1156,
(6R,12R)-4,10-Diphenyl-2,8-bis(2,4,6-trimethylphenyl)-5,6,11,12-
1126 cm–1. HRMS (ESI): calcd. for C28H32NO3 [M + H]+
446.2326; found 446.2327.
tetrahydro-6,12-methanocycloocta[1,2-b:5,6-bЈ]dipyridine 1,7-Diox-
ide (1d): Purified by column chromatography (EtOAc/MeOH, 95:5)
to afford 1d as an off-white solid (250 mg, 78%), m.p. Ͼ 250 °C.
General Procedure for the Synthesis of Pyridine N-Oxides 1a–1d,
2a, 2b, and 3: K2CO3 (691 mg, 5 mmol) was added to a stirred
1
[α]D = +212 (c 1.0, CHCl3). H NMR (CDCl3): δ = 1.81 (s, 6 H),
solution of 8a–8c, 15 (0.5 mmol) or 10a, 10b (1 mmol) in CH2Cl2 2.10 (s, 6 H), 2.29 (s, 6 H), 2.31 (s, 2 H), 3.13 (dd, J = 17.8, 5.6 Hz,
(12 mL) at r.t. and to the resulting suspension m-CPBA (500 mg, 2 H), 3.30 (d, J = 17.8 Hz, 2 H), 4.26 (br. s, 2 H), 6.89 (s, 2 H),
70%, 2 mmol) was added portionwise over 4 h. The reaction mix-
6.91 (s, 2 H), 6.95 (s, 2 H), 7.14–7.21 (m, 4 H), 7.31–7.42 (m, 6
ture was then stirred at r.t. for 24 h, diluted with H2O (25 mL) and H) ppm. 13C NMR (CDCl3): δ = 19.3 (CH3), 20.0 (CH3), 21.1
extracted with EtOAc (2ϫ 20 mL). In the case of 8d, the oxidation
was carried out as described above, but without the addition of
K2CO3, and CH2Cl2 was used for extraction. The combined or-
ganic fraction was washed with saturated NaHCO3 solution and
brine, dried (Na2SO4) and the solvents evaporated. The obtained
residues were purified by column chromatography to afford pyr-
idine N-oxides 1a–1d, 2a, 2b, and 3 as off-white solids.
(CH3), 28.1 (CH2 and CH), 31.7 (CH2), 125.7 (CH), 128.1 (CH),
128.19 (CH), 128.23 (CH), 128.5 (2ϫCH), 130.4 (C), 131.1 (C),
136.2 (C), 136.5 (C), 137.7 (C), 138.4 (C), 138.7 (C), 146.9 (C),
149.5 (C) ppm. IR (KBr): ν = 2917, 1713, 1614, 1462, 1423, 1389,
˜
1273, 1256, 1178, 766, 702 cm–1. HRMS (ESI): calcd. for
C45H43N2O2 [M + H]+ 643.3319; found 643.3327.
(6R,10S)-4-Phenyl-2-(2,4,6-trimethoxyphenyl)-5,6,7,8,9,10-hexa-
(6R,12R)-4,10-Diphenyl-2,8-bis(2,4,6-trimethoxyphenyl)-5,6,11,12- hydro-6,10-methanocycloocta[b]pyridine 1-Oxide (2a): Purified by
tetrahydro-6,12-methanocycloocta[1,2-b:5,6-bЈ]dipyridine 1,7-Diox-
ide (1a): Purified by column chromatography (EtOAc/MeOH/TEA,
column chromatography (CHCl3/MeOH, 99:1) to afford 2a as an
off-white solid (370 mg, 86%), m.p. 156–158 °C. [α]D = +87 (c 1.0,
97:3:3) to afford 1a as an off-white solid (190 mg, 51%), m.p. Ͼ CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.09–1.31 (m, 1 H),
250 °C. [α]D = +202 (c 1.0, CHCl3). 1H NMR (CDCl3): δ = 2.20 1.41–1.73 (m, 4 H), 1.76–1.96 (m, 2 H), 2.08–2.28 (m, 2 H), 2.49
(s, 2 H), 3.16–3.29 (m, 4 H), 3.58 (s, 6 H), 3.70 (s, 6 H), 3.82 (s, 6
(d, J = 18.3 Hz, 1 H), 2.99 (dd, J = 18.3, 7.2 Hz, 1 H), 3.74 (s, 3
H), 4.25 (br. s, 2 H), 6.16 (s, 4 H), 7.06 (s, 2 H), 7.27–7.40 (m, 10 H), 3.75 (s, 3 H), 3.84 (s, 3 H), 4.0 (br. s, 1 H), 6.19 (s, 2 H), 7.0
H) ppm. 13C NMR (CDCl3): δ = 27.87 (CH2), 27.92 (CH), 31.7 (s, 1 H), 7.32–7.47 (m, 5 H) ppm. 13C NMR (75 MHz, CDCl3): δ
(CH2), 55.4 (CH3), 55.8 (CH3), 55.9 (CH3), 90.8 (CH), 91.1 (CH), = 19.3 (CH2), 26.6 (CH), 27.5 (CH2), 29.1 (CH), 31.2 (CH2), 33.4
104.6 (C), 127.7 (CH), 127.9 (CH), 128.3 (CH), 129.0 (CH), 130.8
(CH2), 33.6 (CH2), 55.4 (CH3), 56.0 (2ϫCH3), 90.8 (CH), 91.0
(C), 138.0 (C), 138.3 (C), 141.9 (C), 149.3 (C), 158.9 (C), 159.2 (C), (CH), 105.0 (C), 126.9 (CH), 127.5 (CH), 128.2 (CH), 128.9 (CH),
162.2 (C) ppm. IR (KBr): ν = 2935, 1616, 1603, 1588, 1226, 1205, 132.9 (C), 136.7 (C), 139.0 (C), 141.5 (C), 150.6 (C), 159.08 (C),
˜
1156, 1127 cm–1. HRMS (ESI): calcd. for C45H43N2O8 [M + H]+
739.3022; found 739.3014.
159.12 (C), 162.0 (C) ppm. IR (KBr): ν = 2922, 2855, 1617, 1589,
˜
1455, 1417, 1392, 1286, 1227, 1204, 1154, 1126 cm–1. HRMS (ESI):
calcd. for C27H30NO4 [M + H]+ 432.2169; found 432.2169.
(6R,12R)-4,10-Bis(4-methoxyphenyl)-2,8-bis(2,4,6-trimethoxyphen-
yl)-5,6,11,12-tetrahydro-6,12-methanocycloocta[1,2-b:5,6-bЈ]dipyrid-
ine 1,7-Dioxide (1b): Purified by column chromatography (EtOAc/
(6R,10S)-4-(4-Methoxyphenyl)-2-(2,4,6-trimethoxyphenyl)-
5,6,7,8,9,10-hexahydro-6,10-methanocycloocta[b]pyridine 1-Oxide
MeOH/TEA, 95:5:3) to afford 1b as an off-white solid (170 mg, (2b): Purified by column chromatography (CHCl3/MeOH, 99:1) to
43 %), m.p. Ͼ 250 °C. [α]D = +165 (c 1.0, CHCl3). 1H NMR afford 2b as an off-white solid (360 mg, 78%), m.p. 174–175 °C.
(CDCl3): δ = 2.19 (s, 2 H), 3.19 (dd, J = 18.0, 5.5 Hz, 2 H), 3.27 [α]D = +95 (c 1.0, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 1.10–
(d, J = 18.0 Hz, 2 H), 3.60 (s, 6 H), 3.70 (s, 6 H), 3.82 (s, 12 H),
1.30 (m, 1 H), 1.39–1.71 (m, 4 H), 1.76–1.97 (m, 2 H), 2.07–2.28
4.23 (br. s, 2 H), 6.16 (s, 4 H), 6.88 (d, J = 8.5 Hz, 4 H), 7.03 (s, 2 (m, 2 H), 2.51 (d, J = 18.2 Hz, 1 H), 3.0 (dd, J = 18.2, 7.1 Hz, 1
H), 7.28 (d, J = 8.5 Hz, 4 H) ppm. 13C NMR (CDCl3): δ = 27.96 H), 3.73 (s, 3 H), 3.74 (s, 3 H), 3.83 (s, 3 H), 3.84 (s, 3 H), 4.0 (br.
(CH2), 27.99 (CH2), 31.8 (CH), 55.32 (CH3), 55.39 (CH3), 55.88
s, 1 H), 6.19 (s, 2 H), 6.93–7.0 (m, 3 H), 7.28–7.35 (m, 2 H) ppm.
(CH3), 55.91 (CH3), 90.9 (CH), 91.1 (CH), 104.7 (C), 113.7 (CH), 13C NMR (75 MHz, CDCl3): δ = 19.3 (CH2), 26.7 (CH), 27.5
127.8 (CH), 130.2 (CH), 130.6 (C), 130.8 (C), 137.6 (C), 141.8 (C), (CH2), 29.1 (CH), 31.2 (CH2), 33.5 (CH2), 33.8 (CH2), 55.3 (CH3),
149.2 (C), 159.0 (C), 159.2 (2ϫC), 162.2 (C) ppm. IR (KBr): ν = 55.4 (CH3), 55.96 (CH3), 55.98 (CH3), 90.8 (CH), 91.0 (CH), 105.1
˜
2936, 2837, 1732, 1608, 1587, 1515, 1457, 1277, 1248, 1226, 1204,
(C), 113.7 (CH), 127.0 (CH), 130.1 (CH), 131.2 (C), 133.0 (C),
1156, 1126 cm–1. HRMS (ESI): calcd. for C47H47N2O10 [M + H]+ 136.4 (C), 141.5 (C), 150.5 (C), 159.01 (C), 159.09 (C) 159.13 (C),
799.3225; found 799.3241.
162.0 (C) ppm. IR (KBr): ν = 2930, 2838, 1710, 1606, 1587, 1514,
˜
1459, 1390, 1283, 1245, 1225, 1204, 1154, 1127, 808 cm–1. HRMS
(ESI): calcd. for C28H32NO4 [M + H]+ 462.2275; found 462.2279.
(6R,12R)-4,10-Bis(4-fluorophenyl)-2,8-bis(2,4,6-trimethoxyphenyl)-
5,6,11,12-tetrahydro-6,12-methanocycloocta[1,2-b:5,6-bЈ]dipyridine
1,7-Dioxide (1c): Purified by column chromatography (EtOAc/ (6R,12R)-2,8-Bis(2,4,6-trimethoxyphenyl)-5,6,11,12-tetrahydro-
MeOH/TEA, 97:3:3) to afford 1c as an off-white solid (190 mg, 6,12-methanocycloocta[1,2-b:5,6-bЈ]dipyridine 1,7-Dioxide (3): Puri-
49 %), m.p. Ͼ 250 °C. [α]D = +202 (c 1.0, CHCl3). 1H NMR fied by column chromatography (EtOAc/MeOH/TEA, 95:5:3) to
(CDCl3): δ = 2.19 (s, 2 H), 3.16 (dd, J = 18.0, 5.7 Hz, 2 H), 3.23 afford 3 as an off-white solid (140 mg, 47 %), m.p. Ͼ 250 °C.
1
(d, J = 18.0 Hz, 2 H), 3.62 (s, 6 H), 3.72 (s, 6 H), 3.83 (s, 6 H), [α]D = +484 (c 1.0, CHCl3). H NMR (CDCl3): δ = 2.16 (s, 2 H),
4.22 (br. s, 2 H), 6.18 (s, 4 H), 7.03 (s, 2 H), 7.06 (t, J = 8.7 Hz, 4
3.19 (dd, J = 17.8, 5.7 Hz, 2 H), 3.33 (d, J = 17.8 Hz, 2 H), 3.75
H), 7.29–7.35 (m, 4 H) ppm. 13C NMR (CDCl3): δ = 27.90 (CH2), (s, 12 H), 3.85 (s, 6 H), 4.14 (br. s, 2 H), 6.12 (s, 4 H), 6.94 (d, J =
27.95 (CH2), 31.8 (CH), 55.4 (CH3), 55.9 (CH3), 91.0 (CH), 91.1 8.0 Hz, 2 H), 7.07 (d, J = 8.0 Hz, 2 H) ppm. 13C NMR (CDCl3): δ
(CH), 104.4 (C), 115.3 (d, J = 21.5 Hz, CH), 127.9 (CH), 130.7 (d, = 27.4 (CH), 28.4 (CH2), 32.1 (CH2), 55.4 (CH3), 55.9 (CH3), 56.0
J = 8.1 Hz, CH), 130.8 (C), 134.2 (d, J = 3.4 Hz, C), 136.7 (C), (CH3), 90.7 (CH), 90.8 (CH), 104.6 (C), 125.3 (CH), 126.4 (CH),
142.0 (C), 149.2 (C), 159.0 (C), 159.1 (C), 162.32 (C), 162.36 (d, J
133.4 (C), 142.5 (C), 149.4 (C), 159.0 (C), 159.2 (C), 162.3 (C) ppm.
6366
www.eurjoc.org
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2015, 6359–6369